MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:MEHCQ)

3.500 UNCHANGED
Last Price Updated: 12:57 PM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 3.500
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 3.500
Today's Range 3.500 - 3.500
52wk Range 0.4701 - 6.210
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Eric Jackson Calls Opendoor CEO Remarks Offensive, Tells Carrie Wheeler It Was Retail Investors That Saved Her Company From 'Brink Of Self-Immolation' ↗
Investor Eric Jackson, who ignited Opendoor Technologies Inc.'s (NASDAQ: OPEN) 874% rally last month, is now publicly criticizing the company's CEO, Carrie Wheeler, going as far as to call for her... 
Via Benzinga
News headline image
TTAM Research Institute, A Nonprofit Public Benefit Corporation, Completes The Acquisition of 23andMe Assets
From 23andMe, Inc.
Via GlobeNewswire

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
-2.8%
-2.8%
6 Month
-29.1%
-29.1%
1 Year
+373.3%
+373.3%

More News

Read More
News headline image
23andMe’s $305M Sale To Co-Founder Wojcicki Approved: California Loses Legal Battle Over DNA Privacy ↗
Via Stocktwits
Topics Bankruptcy
News headline image
23andMe Co-Founder Anne Wojcicki Wins Back Company In $305M Deal, Beating Regeneron’s Bid ↗
Via Stocktwits
Topics Bankruptcy
News headline image
23andMe Receives Court Approval for Sale to TTAM Research Institute, a Nonprofit Public Benefit Corporation
From 23andMe, Inc.
Via GlobeNewswire
News headline image
23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process
From 23andMe, Inc.
Via GlobeNewswire
News headline image
23andMe Angles For A Bigger Regeneron Bid As Ex-CEO Steps Up With A Better Offer ↗
Via Investor's Business Daily
Topics Bankruptcy Lawsuit
News headline image
23andMe Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC
From 23andMe, Inc.
Via GlobeNewswire
News headline image
Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale
From 23andMe, Inc.
Via GlobeNewswire
News headline image
Options Corner: Why Boring IBM May Be Ideal Tech Play To Ride Economic Chop ↗
Via Benzinga
News headline image
23andMe Provides Update Regarding Court-Supervised Sale Process
From 23andMe, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is MEHCQ publicly traded?
Yes, MEHCQ is publicly traded.
What exchange does MEHCQ trade on?
MEHCQ trades on the OTC Traded
What is the ticker symbol for MEHCQ?
The ticker symbol for MEHCQ is MEHCQ on the OTC Traded
What is the current price of MEHCQ?
The current price of MEHCQ is 3.500
When was MEHCQ last traded?
The last trade of MEHCQ was at 12/05/25 12:57 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story